Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Capricor Therapeutics Inc...

    NASDAQ: CAPR · Real-Time Price · USD
    7.78
    0.00 (0.00%)
    At close: Aug 15, 2025, 12:51 PM

    Capricor Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 22.27M 25.18M 2.55M 244.9K
    Cost of Revenue
    		 1.43M n/a n/a n/a
    Gross Profit
    		 20.84M 24.11M 1.86M -798
    Operating Income
    		 -42.56M -24.08M -29.7M -20.94M
    Interest Income
    		 2.2M n/a n/a n/a
    Pretax Income
    		 -40.47M -22.29M -29.02M -20.02M
    Net Income
    		 -40.47M -22.29M -29.02M -20.02M
    Selling & General & Admin
    		 14.21M 12.37M 10.32M 7.61M
    Research & Development
    		 49.97M 36.45M 21.82M 13.57M
    Other Expenses
    		 -774K 442.37K 112.55K n/a
    Operating Expenses
    		 63.41M 48.19M 10.43M 21.18M
    Interest Expense
    		 n/a n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 64.83M 49.26M 32.25M 21.18M
    Income Tax Expense
    		 n/a n/a n/a n/a
    Shares Outstanding (Basic)
    		 35.22M 26.78M 24.55M 23.09M
    Shares Outstanding (Diluted)
    		 35.22M 26.78M 24.55M 23.09M
    EPS (Basic)
    		 -1.15 -0.83 -1.18 -0.87
    EPS (Diluted)
    		 -1.15 -0.83 -1.18 -0.87
    EBITDA
    		 -41.14M -23.01M -29.16M -20.69M
    EBIT
    		 -42.56M -24.08M -29.7M -20.94M
    Depreciation & Amortization
    		 1.43M 1.07M 533.13K 245.7K

    Add to Watchlist